Last Posted: Dec 21, 2019
- 'Polygenic' analyses may sharpen disease risk predictions.
Kaiser Jocelyn et al. Science (New York, N.Y.) 2019 12 (6472) 1431 - Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
Callender Tom et al. PLoS medicine 2019 Dec (12) e1002998 - 'Polygenic’ analyses may sharpen disease risk predictions
J Kaiser, Science, December 20, 2019 - Uptake of Polygenic Risk Information among Women at Increased Risk of Breast Cancer.
Yanes Tatiane et al. Clinical genetics 2019 Dec - Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity
L Chen, BioRXIV, December 13, 2019 - Head-to-Head Comparison of Family History of Colorectal Cancer and a Genetic Risk Score for Colorectal Cancer Risk Stratification.
Weigl Korbinian et al. Clinical and translational gastroenterology 2019 Nov - Homogeneity in the association of body mass index with type 2 diabetes across the UK Biobank: A Mendelian randomization study.
Wainberg Michael et al. PLoS medicine 2019 Dec 16(12) e1002982 - Estimating heritability and genetic correlations from large health datasets in the absence of genetic data.
Jia Gengjie et al. Nature communications 2019 Dec 10(1) 5508 - Looking forward 25 years: the future of medicine
Nature Medicine editorial, December 5, 2019 - Predictive impact of rare genomic copy number variations in siblings of individuals with autism spectrum disorders.
D'Abate L et al. Nature communications 2019 Dec 10(1) 5519
.png)
No hay comentarios:
Publicar un comentario